Martin Frydland, MD, PhD (@joyland2704) 's Twitter Profile
Martin Frydland, MD, PhD

@joyland2704

Cardiology registrar. Located in Copenhagen, Denmark. Primarily interested in full spectrum of Acute Heart Failure and biomarkers. @cardiac_group @dobermann_rct

ID: 457519181

calendar_today07-01-2012 14:18:25

1,1K Tweet

631 Followers

892 Following

RigsHeart 🫀🚨 (@rigsheart) 's Twitter Profile Photo

📊 Sneak peek! Christina Byrne and team validated the NULL-PLEASE score in 3,881 OHCA patients 🇩🇰 🔢 Score ≥9 = 98% chance of death or brain injury 🧠 But: outliers exist! AUCs around 0.8. That’s no joke. Big win for resus prognostication! academic.oup.com/ehjacc/advance…

Nikolay Novitskiy (@novitskiynic) 's Twitter Profile Photo

Is decongestion the goal during acute heart failure treatment? PRO by Frederik H. Verbrugge 📍Congestion should be assessed in a normal hydration status 📍Decongestion # dehydration 📍Decongestion = desalinization #HeartFailure2025

Is decongestion the goal during acute heart failure treatment?

PRO by <a href="/FH_Verbrugge/">Frederik H. Verbrugge</a> 

📍Congestion should be assessed in a normal hydration status
📍Decongestion # dehydration
📍Decongestion = desalinization

#HeartFailure2025
RigsHeart 🫀🚨 (@rigsheart) 's Twitter Profile Photo

🚨A new substudy of #BOXtrial just out🚨 Jakob Josiassen et al. found that: 📢 Among #OHCA patients, preexisting #diabetes was associated with ⬆️1-yr all-cause mortality ☠️ 📢No differences in outcomes were observed across #diabetes status among #OHCA patients based on duration

🚨A new substudy of #BOXtrial just out🚨

<a href="/JosiassenJakob/">Jakob Josiassen</a> et al. found that:
📢 Among #OHCA patients, preexisting #diabetes was associated with ⬆️1-yr all-cause mortality ☠️
📢No differences in outcomes were observed across #diabetes status among #OHCA patients based on duration
Muthu Vaduganathan (@mvaduganathan) 's Twitter Profile Photo

#GDMT has now arrived for #HFpEF #SGLT2i (class I) and #nsMRA (class IIa) recommendations in initial global guidelines jstage.jst.go.jp/article/circj/… #HeartFailure2025

#GDMT has now arrived for #HFpEF

#SGLT2i (class I) and #nsMRA (class IIa) recommendations in initial global guidelines

jstage.jst.go.jp/article/circj/…

#HeartFailure2025
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴 The Medical Treatment of Cardiogenic Shock #OpenAccess #Review 🔹sciencedirect.com/science/articl… #CardioEd #CardioTwitter #cardiology #ECG #MedEd #cardiovascular #internalmedicine #EKG

🔴 The Medical Treatment of Cardiogenic Shock #OpenAccess #Review 

🔹sciencedirect.com/science/articl… 
#CardioEd #CardioTwitter #cardiology #ECG #MedEd #cardiovascular #internalmedicine #EKG
Abdul Hakeem MD (@ahakeem143) 's Twitter Profile Photo

Rivaroxaban vs Warfarin in Acute Left Ventricular Thrombus Following Myocardial Infarction: RIVAWAR, An Open-Label RCT | JACC: Advances jacc.org/doi/10.1016/j.…

Rivaroxaban vs Warfarin in Acute Left Ventricular Thrombus Following Myocardial Infarction: RIVAWAR, An Open-Label RCT | JACC: Advances jacc.org/doi/10.1016/j.…
Konstantin Krychtiuk (@krychtiukmd) 's Twitter Profile Photo

Cardiogenic shock: diagnosis, phenotyping and management - check out our international collaborative review in Intensive Care Medicine led by Jacob Møller and Holger Thiele Alastair Proudfoot #ECLS #ECMO #Impella #cardiogenicshock link.springer.com/article/10.100…

Cardiogenic shock: diagnosis, phenotyping and management

- check out our international collaborative review in <a href="/yourICM/">Intensive Care Medicine</a> led by Jacob Møller and <a href="/thiele_holger/">Holger Thiele</a> 

<a href="/ICUDocAP/">Alastair Proudfoot</a> #ECLS #ECMO #Impella #cardiogenicshock 

link.springer.com/article/10.100…
Abdulla A. Damluji, MD, PhD (@drdamluji) 's Twitter Profile Photo

Clinical Practice of Surgical Treatment for Left-Sided Infective Endocarditis: Nationwide Data from the NIDUS Registry: Circulation 🥸 1/2 of pts with indication for Sx, underwent surgery for endocarditis 👇👇👇

Clinical Practice of Surgical Treatment for Left-Sided Infective Endocarditis: Nationwide Data from the NIDUS Registry: <a href="/CircAHA/">Circulation</a> 

🥸 1/2 of pts with indication for Sx, underwent surgery for endocarditis 

👇👇👇
CTCPR Trials & CIRL (@ctcpr_) 's Twitter Profile Photo

Come and hear about the latest science from CTCPR Trials & CIRL at #ESCcongress Researchers from CTCPR Trials & CIRL will present 32 abstracts including 2 late-breaking RCT presentations – And publish several simultaneous publications. STAY TUNED! 👉 See our 4-day program below – Sunday´s highlights

Come and hear about the latest science from
<a href="/CTCPR_/">CTCPR Trials & CIRL</a> at #ESCcongress
Researchers from <a href="/CTCPR_/">CTCPR Trials & CIRL</a>  will present 32 abstracts including 2 late-breaking RCT presentations – And publish several simultaneous publications. 
STAY TUNED! 👉 See our 4-day program below –  Sunday´s highlights
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 (@drmarthagulati) 's Twitter Profile Photo

🚨10 electrifying Hot Line sessions and 40+ pivotal trials debuting at #ESCCongress 2025 in Madrid! ‼️Trials targeting long‑held theories related to beta‑blockers post MI, digoxin for #HFrEF, antiplatelets & anticoagulants, novel treatments for Chagas, HCM, hypertension

🚨10 electrifying Hot Line sessions and 40+ pivotal trials debuting at #ESCCongress 2025 in Madrid!

‼️Trials targeting long‑held theories related to beta‑blockers post MI, digoxin for #HFrEF, antiplatelets &amp; anticoagulants, novel treatments for Chagas, HCM, hypertension
John Mandrola, MD (@drjohnm) 's Twitter Profile Photo

No trial better explains the importance of evidence than REVIVED BCIS. It boggles my mind that it was negative Divaka Perera is correct, but try telling 99% of American cardiologists We still cath new LV dys pts TO FIND LESIONS TO REVASC despite negative trials #ESC2025

Novi Yanti Sari (@slumberbell) 's Twitter Profile Photo

🔥Fresh from the HotLine 1 #ESCCongress #WCCardio‼️ DIGIT-HF: #Digitoxin use in #HFrEF by #UdoBavendiek: 📍N:1212 of patients with chronic HFrEF, NYHA II + LVEF ≤30% OR NYHA III-IV + LVEF ≤40% on GDMT >= 6months 📍Digitoxin ⬇️risk of composite of all-cause death or worsening

🔥Fresh from the HotLine 1 #ESCCongress #WCCardio‼️

DIGIT-HF: #Digitoxin use in #HFrEF by #UdoBavendiek:

📍N:1212 of patients with chronic HFrEF, NYHA II + LVEF ≤30% OR NYHA III-IV + LVEF ≤40% on GDMT &gt;= 6months
📍Digitoxin ⬇️risk of composite of all-cause death or worsening
RigsHeart 🫀🚨 (@rigsheart) 's Twitter Profile Photo

🎉 Congratulations to Dr. Christian Jøns, the #POTCAST Study Group, and collaborators on the impressive #Hotline presentation & simultaneous NEJM publication 🔥🔥🔥 #ESCCongress2025 #Epeeps

🎉 Congratulations to Dr. Christian Jøns, the #POTCAST Study Group, and collaborators on the impressive #Hotline presentation &amp; simultaneous <a href="/NEJM/">NEJM</a> publication 🔥🔥🔥

#ESCCongress2025 #Epeeps
European Society of Cardiology (@escardio) 's Twitter Profile Photo

#ESCCongressVisuals for Hotline 1: Will targeted serum potassium levels further optimize outcomes in patients who received an ICD? Check out the results of the POTCAST Study.👇 Will a Zio Patch monitor permit better detection of AF following continuous rhythm tracing for two

#ESCCongressVisuals for Hotline 1:

Will targeted serum potassium levels further optimize outcomes in patients who received an ICD? Check out the results of the POTCAST Study.👇

Will a Zio Patch monitor permit better detection of AF following continuous rhythm tracing for two
Anil Makam (@anilmakam) 's Twitter Profile Photo

Here are my takeaways for the 7 most relevant and important #ESCCongress2025 for generalists AQUATIC, HI-PRO, RETREAT-FRAIL, DIGIT-HF, DAN-RSV were most practicing changing POTCAST was most contentious - not as billed

Muthu Vaduganathan (@mvaduganathan) 's Twitter Profile Photo

Novel Devices for #HFpEF 🔥 #ELEVATEHFpEF Personalized Pacing #CASTLEHFpEF AF Ablation #AIMHigher Cardiac Contractility Modulator #RESPONDERHF #ALLAY Interatrial Shunt #REBALANCE Splanchnic Nerve Ablation #ALLEVIATEHF Insertable Monitor Watch this space! jacc.org/doi/10.1016/j.…

Novel Devices for #HFpEF 🔥

#ELEVATEHFpEF Personalized Pacing
#CASTLEHFpEF AF Ablation
#AIMHigher Cardiac Contractility Modulator
#RESPONDERHF #ALLAY Interatrial Shunt
#REBALANCE Splanchnic Nerve Ablation
#ALLEVIATEHF Insertable Monitor

Watch this space!
jacc.org/doi/10.1016/j.…